Results 211 to 220 of about 42,609 (234)

Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial

Lancet, The, 2020
Christopher Butler, Alike W Van Der Velden, Emily Bongard   +2 more
exaly  

Oseltamivir

Reactions Weekly, 2019
openaire   +2 more sources

Oseltamivir

Reactions Weekly, 2022
openaire   +1 more source

Oseltamivir

Reactions Weekly, 2018
openaire   +2 more sources

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

Lancet, The, 2004
Frederick G Hayden, Yoshihiro Kawaoka
exaly  

Oseltamivir

2007
openaire   +1 more source

Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza

New England Journal of Medicine, 1999
Frederick G Hayden, Robert L Atmar, Margo L Schilling   +2 more
exaly  

Synthetic Approaches to the Neuraminidase Inhibitors Zanamivir (Relenza) and Oseltamivir Phosphate (Tamiflu) for the Treatment of Influenza

Chemical Reviews, 2009
Javier Magano
exaly  

Efficacy of Clarithromycin‐Naproxen‐Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open‐label Randomized, Controlled, Phase IIb/III Trial

Chest, 2017
I. Hung, K. K. To, J. Chan, V. Cheng, K. Liu, A. Tam, T. Chan, A. J. Zhang, P. Li, T. Wong, R. Zhang, Michael K. Cheung, W. Leung, J. Lau, Manson Fok, Honglin Chen, Kwok-Hung Chan, K. Yuen   +17 more
semanticscholar   +1 more source

High‐Yielding Synthesis of the Anti‐Influenza Neuramidase Inhibitor (−)‐Oseltamivir by Three “One‐Pot” Operations

Angewandte Chemie - International Edition, 2009
Hayato Ishikawa, Yujiro Hayashi
exaly